You are now leaving the Kedrion website. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it.
  1. CORPORATE - 09-04-2020

    Coronavirus, from Plasma an anti Covid-19 treatment

    Kedrion’s commitment to find a treatment from convalescent patient plasma

    read more 
  2. CORPORATE - 25-03-2020

    Letter to patient associations and scientific organizations

    Communication from Paolo Marcucci, Chairman & CEO of Kedrion

    read more 
  3. CORPORATE - 11-07-2017

    Building Bridges: An eminent specialist diagnoses a patient in distress

    Professor Hermann Wolf treats a special case in Vienna and Kedrion pitches in

    read more 


For more information please contact: